Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
about
Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specificCytokines as new treatment targets in chronic heart failureMyocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesisInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathyA study of the adult zebrafish ventricular function by retrospective Doppler-gated ultrahigh-frame-rate echocardiographyTauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress.Pro/Anti-inflammatory cytokine imbalance in postischemic left ventricular remodelingHeart regeneration in adult MRL miceUrokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophagesClinical importance of beta-adrenoceptor polymorphisms in cardiovascular disease.Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking.Immunological and dermatological impact of progesterone.Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice.Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.The yin/yang of innate stress responses in the heart.Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.TNF and congestive heart failure: therapeutic possibilities.miR-146a targets Fos expression in human cardiac cellsTumor necrosis factor-alpha, biologic agents and cardiovascular risk.The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failureRelaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.Recent advances of TNF-alpha antagonists in rheumatoid arthritis and chronic heart failure.Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammation.Role of NonO-histone interaction in TNFalpha-suppressed prolyl-4-hydroxylase alpha1How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Oxidative and nitrosative stress and fibrogenic response.Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium.The pathogenesis of cardiac fibrosis.IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.Effect of interleukin-15 on the course of myocarditis in Coxsackievirus B3-infected BALB/c mice.Aging, exercise, and extracellular matrix in the heartOxidative stress and left ventricular remodelling after myocardial infarction.Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardiumBiomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload.Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.Morphological and molecular changes of the myocardium after left ventricular mechanical supportThe G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy.
P2860
Q24798801-40EBFB9E-B1E2-4871-A56F-4906A848AE11Q24799394-2C55C309-831F-4D30-AEC9-91C39BE8330CQ24812557-BAD6259A-B82C-46BE-8C11-378903371350Q27001165-E0D3742F-725E-4729-A739-FDC9CFFD8BE6Q30435068-C535247E-DC90-41E0-B40F-14144609CD48Q33585295-50349ACC-22F3-47DC-8482-5D3D1CC19E01Q33836204-0FF3E2D6-F5FE-43F8-8745-E441111E64B0Q33933931-86DB3122-D58B-486D-A47E-5A330C59F67CQ34639045-0C33A014-01FF-4178-88D1-961837E281B8Q34706690-2CCF95CF-F30E-4173-BA7B-B26F31D5AF39Q34794044-4CB7D59C-CE32-41A2-A875-2474DE2A47BCQ34847457-E36B20A8-C0E8-4DCA-9B96-F458C104172FQ35083462-F18B160E-B622-46F6-93C7-DB2A7239FEDDQ35086445-7634B666-475E-48E0-922C-DABDA5A82B21Q35176886-DB081611-5E99-4D6B-8DD0-27A1F45EE658Q35553540-41202FBA-D6E0-4CB6-BC43-C21D8ED9EDE1Q35607377-D55FA3B6-2BBE-443C-BFA0-C79EA8B95B04Q35782883-A182A661-9330-4D9A-A7AE-4E7A18CDCA51Q36090842-0156799F-D833-4561-A87C-8C4F2AA17D21Q36283524-E2EB9334-4F38-4231-960C-1826CAD289C5Q36669219-A38D96E4-F12F-4B01-93CE-1630A4279CD5Q36711865-74B41C17-FE51-4BD6-8F5D-A2E03E11FA43Q36810269-4AFC3330-AD52-4611-A92F-70E97E56FC8AQ36850775-0142C6B6-98E3-4EC9-893A-F3E8A602DDD1Q36983132-BC5112C5-28CC-4895-BE2E-73118748BF47Q37004826-A4CDF218-5B79-4167-A8E3-14B1F319FBFBQ37037061-1B425D88-2B21-444A-B97C-428F64D92A9FQ37090568-466C6B09-F4F2-49CD-B7B2-06EA1C7BEE83Q37161329-F0E1998C-66F3-4057-BC7B-92CFBD80E7DEQ37293969-9BCE2953-FAFB-4888-A753-9A9269E1F510Q37295199-2ED3F9AC-C0A6-48E5-8EE3-9DDDB617060AQ37332371-11841C65-AA9C-4C48-BBC5-0C47DCE984E3Q37338724-B7C047C4-E44D-496B-A9AB-21532DA9258FQ37356852-899935A3-B2F7-4A8D-8071-43D0780DC5C7Q37366263-365F0057-B931-493D-965D-D4F3BC1E0187Q37412421-831CC56F-3A3C-4CF3-A6DE-F7A6CC73347EQ37434655-EF30C4B5-EE03-4737-A740-A936FE702362Q37594085-0E230F11-6ABA-4BDD-A50B-5962B1182FDFQ37638247-21D6CB25-596E-4CE2-84C1-90C612EBB7CBQ37687213-CC0C64DF-AA63-488C-AE17-62E8DC097331
P2860
Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@ast
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@en
type
label
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@ast
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@en
prefLabel
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@ast
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@en
P2093
P2860
P356
P1476
Myocardial extracellular matri ...... necrosis factor alpha therapy.
@en
P2093
A M Feldman
C F McTiernan
S C Watkins
T Kadokami
P2860
P304
12746-12751
P356
10.1073/PNAS.97.23.12746
P407
P577
2000-11-01T00:00:00Z